Kimberly J Jenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kimberly J Jenko has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Emily K. Osterweil
Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, UK
1 shared publication - Mark F. Bear
The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, USA
1 shared publication - Masahiro Fujita
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
1 shared publication - Robert B. Innis
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication - Talakad G Lohith
Molecular Imaging Branch, National Institute of Mental Health, 10 Center Drive, Bethesda, MD 20892-1026, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Springer Nature in Molecular Autism
- Vol. 4 (1) , 15
Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
Fragile X syndrome (FXS) is a common inherited form of intellectual disability caused by loss of function of the fragile X mental retardation protein. Recent animal studies suggest that upregulated downstream signaling by metabotropic glutamate receptor 5 (mGluR5) might be an important mechanism for cognitive and behavioral abnormalities associated with FXS. However, mGluR5 density in human FXS remains unknown.
- 1 January 2013
- Published by Springer Nature in Molecular Autism
- Vol. 4 (1) , 15
Open AccessIs metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?
Fragile X syndrome (FXS) is a common inherited form of intellectual disability caused by loss of function of the fragile X mental retardation protein. Recent animal studies suggest that upregulated downstream signaling by metabotropic glutamate receptor 5 (mGluR5) might be an important mechanism for cognitive and behavioral abnormalities associated with FXS. However, mGluR5 density in human FXS remains unknown.